PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. The MFPs will be announced publicly in September 2024 and go into effect on January 1, 2026.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. billion by 2026, according to research by the Business Research Company. billion in 2021 to $9.23 References.

Marketing 98

Marketing Pharma Healthcare Healthcare 98

European Pharmaceutical Review

FEBRUARY 12, 2024

Liam Dunne, MSD Biotech Site Lead, explains that the site operates at the forefront of science and technology with 15,000L-scale, repeatable, robust manufacturing processes to produce highly sensitive monoclonal antibodies (mAbs). How does it do this? Since 2021, Liam Dunne is the site head of MSD Biotech in Dublin.

Manufacturing 98

Manufacturing Medicine Leads Patients 98

Pharmaceutical Technology

MAY 29, 2023

GlobalData’s Blockchain Market Size, Share, Trends, and Segment Forecast to 2030 report offers insights on application of blockchain in healthcare and other key sectors. GlobalData identified 1 blockchain-related sentences in the company's filings - 0% of all sentences - and an increase of 100% in Q1 2023 compared with Q1 2022.

Pharmaceutical 52

Pharmaceutical Marketing Competition Medicine 52

pharmaphorum

JANUARY 18, 2023

That pressure can lead to diagnostic errors, with a 2018 study suggesting that there are 40 million errors involving imaging worldwide every year. billion) in 2021, around 10% of the group’s total healthcare revenues. The business generated sales of €1.8 billion (approximately $1.9

Medical 59

Medical Pharma Media Sales 59

Clarivate

OCTOBER 25, 2023

The initial list, which takes effect in 2026, has the potential to roil formularies since it includes a mix of high-volume, preferred brands and a group of high-cost specialty drugs for autoimmune conditions (psoriasis) and cancer. Part D cannot cover drugs covered under Part A or Part B , forcing them to be addressed separately.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

PM360

APRIL 7, 2023

Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders. This will create confusion in the marketplace and may possibly lead to delivery of misinformation to healthcare providers (HCPs) regarding a brand’s drug coverage,” Bambalas says.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

Clarify Health

MAY 4, 2022

Population health management is best supported by a data-driven approach with a structured analytics process driven by skilled and competent healthcare leaders and clinicians. Reports estimate that the healthcare analytics market size is expected to grow to $75.1 billion by 2026.

Management 52

Management Healthcare Healthcare Training 52

Clarify Health

MAY 4, 2022

Population health management is best supported by a data-driven approach with a structured analytics process driven by skilled and competent healthcare leaders and clinicians. Reports estimate that the healthcare analytics market size is expected to grow to $75.1 billion by 2026. Get valuable Insights delivered to your inbox.

Management 52

Management Healthcare Healthcare Training 52

Pharmaceutical Technology

JANUARY 16, 2023

Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets. What is the Global Healthcare and Pharma Market Q2 Outlook?

Pharma 64

Pharma Pharmaceutical Manufacturing Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets. What is the Global Healthcare and Pharma Market Q2 Outlook?

Pharma 52

Pharma Pharmaceutical Manufacturing Marketing 52

pharmaphorum

JANUARY 29, 2023

With the population ageing, the need for healthcare is growing fast: between 2015 and 2050, the proportion of the world’s population over 60 years old will nearly double from 12% to 22%, according to the World Health Organization. Secondly, pressure on healthcare spending is leading to greater consolidation.

Healthcare 98

Healthcare Healthcare Manufacturing Marketing 98

PM360

SEPTEMBER 21, 2023

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. United States Specialty Pharmaceuticals Market & Forecast 2020-2026,” BusinessWire, December 8, 2020. IQVIA Institute, March 2022.

Prescription 52

Prescription Medical Patients Distribution 52

pharmaphorum

JANUARY 4, 2023

The CGT market in Europe, for example, is projected to increase by 23% by 2026. Robust cryogenic infrastructure in strategic locations across the globe – ideally close to processing facilities and healthcare providers – is necessary to enable timely and reliable access to these therapies around the world and accelerate time to treatment.

Transportation 98

Transportation Manufacturing Patients Networking 98

pharmaphorum

JULY 26, 2022

The Dutch biotech will book around $235 million from a private placement led by Frazier Healthcare Partners and Bain Capital Life Sciences and funds held in Frazier’s trust account. So why will obicetrapib avoid the pitfalls of its predecessors?

Side effects 52

Side effects Safety Pharma Patients 52

Clarify Health

APRIL 26, 2022

Artificial intelligence (AI) has the potential to affect healthcare in profound ways — propelling better data-driven decisions on diagnoses, treatments, and population health management. health system realize $150 billion in savings by 2026. During the panel, Dr. Ramadoss gave examples of AI applications in healthcare.

Healthcare 52

Healthcare Healthcare Management Media 52

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. That impacts launches most. Lastly, the growing economic crisis creates increasing challenge for medicines funding.

Doctors 59

Doctors Medicine Marketing Sales 59

Medico Reach

MARCH 24, 2023

As a result, a global approach to healthcare has emerged continually over the years. This global approach to healthcare is known as precision medicine which has emerged in treatments like immunotherapy. It is estimated that global oncology spending will exceed $300 billion by 2026.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Medico Reach

MARCH 24, 2023

As a result, a global approach to healthcare has emerged continually over the years. This global approach to healthcare is known as precision medicine which has emerged in treatments like immunotherapy. It is estimated that global oncology spending will exceed $300 billion by 2026.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Infuse Medical

MARCH 12, 2025

Medical sales reps frequently struggle to explain intricate device features and benefits, especially when their audience consists of busy healthcare professionals with limited time and high expectations. Infuse Med is leading the charge, providing cutting-edge sales enablement solutions. trillion by 2026 , according to IDC.

Sales technology 130

Sales technology Medical sales Sales Medical 130

Nixon Gwilt Law

JANUARY 14, 2025

2024 was a pivotal year for AI in healthcare. Venture investment skyrocketed, partnerships between leading AI startups and health systems took shape, and policymakers across the globe grappled with AIs implications for consumer safety and algorithmic transparency. Two are noteworthy from a healthcare perspective.

Healthcare 52

Healthcare Healthcare Food and Drug Administration Government 52

Healthcare Success

JANUARY 27, 2025

For healthcare marketers, we share the importance of simplicity, clarity, and local outreach in connecting with tech-savvy boomers and aging Gen Xers, as well as the strategies needed to avoid ANOC (Annual Notice of Change) shock and reduce member churn. United Healthcare and Human alone control 47%.

Marketing 65

Marketing Education Media Leads 65

Clarivate

OCTOBER 17, 2024

Healthcare delivery has not been the hottest topic on the campaign trail this election season, despite sharp policy differences between the candidates and parties. These prior actions align with the Biden Administration’s policy of strict antitrust enforcement, particularly concerning healthcare. During the Sept.

Healthcare 52

Healthcare Healthcare Government Insurance 52